➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Dow
Colorcon
Express Scripts
Medtronic

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-02-15
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Plaintiff Referred To
Parties VERTICAL PHARMACEUTICALS, LLC
Patents 8,389,578; 8,741,343; 8,796,337; 8,889,740; 8,895,614; 8,895,615; 8,895,616; 8,895,617; 8,895,618; 9,867,791; 9,867,792; 9,867,793
Attorneys Adam Wyatt Poff
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-02-15 1 claim of U.S. Patent Nos. 8,389,578 (“the ’578 patent”); 8,741,343 (“the ’343 patent”); 8,796,337 (“…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Merck
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.